Higher values indicate aggressive inorganic growth strategies in the medical device space.
Captures the specific portion of goodwill added to the MedTech segment balance sheet resulting from new business combina...
Commonly reported by peers in the medical technology sector during periods of consolidation.
jnj_segment_medtech_goodwill_related_to_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $73.00M | $122.00M | $0.00 | $10.86B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.49B | $73.00M | $2.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | +67.1% | -100.0% | — | -100.0% | — | — | — | — | — | -99.0% | -97.3% | -100.0% | — | — | — | — |
| YoY Change | — | — | — | — | — | — | — | -100.0% | -100.0% | — | -100.0% | — | — | — | — | — | -100.0% | -100.0% | -100.0% | — |